Armenia vs Georgia: Average cost of drugs for extensively drug-resistant tuberculosis

Armenia
4,190 constant 2022 US$
in 2024
Georgia
4,500 constant 2022 US$
in 2022
Armenia rank
16th
Georgia rank
14th

Average cost of drugs for extensively drug-resistant tuberculosis over time

  • Armenia
  • Georgia
02.0k4.0k6.0k8.0k201820212024

How they compare

Georgia currently reports 4,500 constant 2022 US$ against 4,190 constant 2022 US$ in Armenia, a difference of 310 constant 2022 US$.

That makes Georgia's figure about 1.1 times Armenia's.

Armenia ranks 16th and Georgia ranks 14th of 56 countries.

Across the 2 decades both report, Armenia averaged higher in 1 and Georgia in 1.

Head to head by decade

Decade Armenia Georgia Difference Ahead
2010s 4,900 constant 2022 US$ 6,000 constant 2022 US$ 1,100 constant 2022 US$ Georgia
2020s 4,900 constant 2022 US$ 4,533 constant 2022 US$ 366.67 constant 2022 US$ Armenia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher average cost of drugs for extensively drug-resistant tuberculosis, Armenia or Georgia?
Georgia, at 4,500 constant 2022 US$ against 4,190 constant 2022 US$ in Armenia as of 2022.
What is the difference in average cost of drugs for extensively drug-resistant tuberculosis between Armenia and Georgia?
310 constant 2022 US$, with Georgia ahead.
How do Armenia and Georgia rank globally for average cost of drugs for extensively drug-resistant tuberculosis?
Armenia ranks 16th and Georgia ranks 14th of 56 countries.
Where does this data come from?
WHO (2025) – with minor processing by Our World in Data, published as Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Average cost of drugs for extensively drug-resistant tuberculosis
Unit
constant 2022 US$
Source
WHO (2025) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
56 places, 394 data points, 2017–2024
Last refreshed

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.